Inactive Instrument

All News Aastrom Biosciences Inc Nasdaq

Equities

US00253U4040

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	Mar. 15	MT
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	Mar. 13	MT
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	Mar. 11	MT
Truist Securities Raises Vericel's Price Target to $54 From $51, Keeps Buy Rating	Mar. 01	MT
HC Wainwright Adjusts Price Target on Vericel to $53 From $46, Keeps Buy Rating	Mar. 01	MT
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	Feb. 29	MT
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Transcript : Vericel Corporation, Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	Feb. 29	CI
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q4 Revenue $65M, vs. Street Est of $64M	Feb. 29	MT
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	Feb. 29	GL
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	Feb. 29	AQ
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	Feb. 27	GL
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	Feb. 27	AQ
Vericel Insider Sold Shares Worth $1,677,200, According to a Recent SEC Filing	Feb. 16	MT
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024	Feb. 15	GL
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024	Feb. 15	AQ
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024	Feb. 05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Aastrom Biosciences Inc Nasdaq

Equities

US00253U4040

All News

Filters